by Truveta News | Oct 9, 2024 | News
Today, Truveta was featured as #3 on LinkedIn’s inaugural Top Startups in Seattle list. The ranking highlights ten growing start-up companies in the Seattle area. Last month, Truveta was also included on the national LinkedIn’s Top Startups list for 2024, which...
by Truveta staff | Sep 26, 2024 | Technology
Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is critical in mitigating HF morbidity and mortality, but few new treatment strategies have emerged...
by Truveta staff | Sep 19, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased significantly...
by Truveta staff | Sep 11, 2024 | Research
The overall trends of hospitalizations associated with viral gastroenteritis – norovirus and rotavirus – show a steady decrease over the last few months, leading to a rate of 0.04% in August 2024 in the overall population. However, we see first indicators that the...
by Truveta News | Sep 4, 2024 | News
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has partnered with Truveta to use its electronic health record (EHR) data to drive comparative, cost-effectiveness, and outcomes research....
